Clinical Trials Logo

Clinical Trial Summary

This registry aims to collect informations about patients with endocrine tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube) who undergo endocrine surgical procedures. This registry is part of the Eurocrine Project.


Clinical Trial Description

The EUROCRINE project aims to decrease morbidity and mortality of rare endocrine tumours, by means of a pan-European database. Recording and accessing data at the European level, makes it possible to identify these tumours, which cannot be distinguished at local or national level, because of their extreme rarity. Dissemination of results aims to raise clinical standards and reduce differences in practise between clinics and member states, and thereby diminish morbidity and mortality. Comparison of practice and outcomes will be especially interesting for centres wanting to improve their standards to what is currently considered best practice. EUROCRINE will be a key means by which the medical profession, researchers, health policy makers, and not least patients, can benefit from an increase in knowledge related to diagnosis, treatment, and future clinical research in the field of rare endocrine tumours. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03410394
Study type Observational [Patient Registry]
Source Central Hospital, Nancy, France
Contact laurent Brunaud, MD, PhD
Email l.brunaud@chru-nancy.fr
Status Recruiting
Phase
Start date January 1, 2015
Completion date January 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05974696 - A Research Registry on Aggressive PitNETs
Completed NCT02330497 - Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor N/A